Literature DB >> 19303662

Candida colonisation as a source for candidaemia.

L N Miranda1, I M van der Heijden, S F Costa, A P I Sousa, R A Sienra, S Gobara, C R Santos, R D Lobo, V P Pessoa, A S Levin.   

Abstract

Candida spp. are important healthcare-associated pathogens. Identifying the source of infection is important for prevention and control strategies. The objective of this study was to evaluate candida colonisation sites as potential sources for candidaemia. Sixty-three consecutive patients with a positive blood culture for candida were included. Surveillance cultures were collected from urine, rectum, oropharynx, skin, intravascular catheter tip and skin around catheter. Molecular typing was performed when the same species of candida was isolated from blood and surveillance sites of a patient. C. albicans was associated with 42% of candidaemias, C. parapsilosis 33%, C. tropicalis 16% and C. guilliermondii, C. krusei, C. glabrata, C. holmii and C. metapsilosis were all 2% each. Six of 10 C. parapsilosis catheter tip isolates were indistinguishable from corresponding blood isolates (all in neonates). C. albicans isolates from blood were indistinguishable from corresponding gastrointestinal tract isolates in 13 of 26 patients and from catheter tip isolates in two patients. In conclusion, the results suggest that gastrointestinal colonisation is the probable source of C. albicans candidaemia and C. parapsilosis is exogenous.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19303662     DOI: 10.1016/j.jhin.2009.02.009

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  90 in total

Review 1.  Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Authors:  Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 2.  Murine models of Candida gastrointestinal colonization and dissemination.

Authors:  Andrew Y Koh
Journal:  Eukaryot Cell       Date:  2013-09-13

Review 3.  Inflammation and gastrointestinal Candida colonization.

Authors:  Carol A Kumamoto
Journal:  Curr Opin Microbiol       Date:  2011-07-28       Impact factor: 7.934

4.  Iron Chelator Deferasirox Reduces Candida albicans Invasion of Oral Epithelial Cells and Infection Levels in Murine Oropharyngeal Candidiasis.

Authors:  Sumant Puri; Rohitashw Kumar; Isolde G Rojas; Ornella Salvatori; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

Review 5.  Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.

Authors:  David S Perlin
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

6.  MIG1 Regulates Resistance of Candida albicans against the Fungistatic Effect of Weak Organic Acids.

Authors:  Fabien Cottier; Alrina Shin Min Tan; Xiaoli Xu; Yue Wang; Norman Pavelka
Journal:  Eukaryot Cell       Date:  2015-08-21

Review 7.  Host responses to Candida albicans: Th17 cells and mucosal candidiasis.

Authors:  Heather R Conti; Sarah L Gaffen
Journal:  Microbes Infect       Date:  2010-04-08       Impact factor: 2.700

Review 8.  Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients.

Authors:  Andrew Y Koh
Journal:  Clin Chem       Date:  2017-07-18       Impact factor: 8.327

9.  Yeast oropharyngeal colonization in human immunodeficiency virus-infected patients in central taiwan.

Authors:  Mao-Wang Ho; Yun-Liang Yang; Chih-Chao Lin; Chih-Yu Chi; Hui-Ting Chen; Po-Chang Lin; Li-Yun Hsieh; Chia-Hui Chou; Wen-Li Chu; Chiou-Pyng Wu; Tsai-Ling Lauderdale; Hsiu-Jung Lo
Journal:  Mycopathologia       Date:  2014-05-08       Impact factor: 2.574

Review 10.  Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis.

Authors:  Mohan Pammi; Linda Holland; Geraldine Butler; Attila Gacser; Joseph M Bliss
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.